These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21078867)

  • 21. Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating.
    Basso C; Vergani P; Nairn AC; Gadsby DC
    J Gen Physiol; 2003 Sep; 122(3):333-48. PubMed ID: 12939393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of alpha-aminoazaheterocycle-methylglyoxal adducts as a new class of high-affinity inhibitors of cystic fibrosis transmembrane conductance regulator chloride channels.
    Routaboul C; Norez C; Melin P; Molina MC; Boucherle B; Bossard F; Noel S; Robert R; Gauthier C; Becq F; Décout JL
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1023-35. PubMed ID: 17578899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cluster of negative charges at the amino terminal tail of CFTR regulates ATP-dependent channel gating.
    Fu J; Ji HL; Naren AP; Kirk KL
    J Physiol; 2001 Oct; 536(Pt 2):459-70. PubMed ID: 11600681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positioning of extracellular loop 1 affects pore gating of the cystic fibrosis transmembrane conductance regulator.
    Infield DT; Cui G; Kuang C; McCarty NA
    Am J Physiol Lung Cell Mol Physiol; 2016 Mar; 310(5):L403-14. PubMed ID: 26684250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATP hydrolysis cycles and the gating of CFTR Cl- channels.
    Gadsby DC; Dousmanis AG; Nairn AC
    Acta Physiol Scand Suppl; 1998 Aug; 643():247-56. PubMed ID: 9789567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle.
    Jih KY; Hwang TC
    Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4404-9. PubMed ID: 23440202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between permeation and gating in a putative pore domain mutant in the cystic fibrosis transmembrane conductance regulator.
    Zhang ZR; McDonough SI; McCarty NA
    Biophys J; 2000 Jul; 79(1):298-313. PubMed ID: 10866956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single amino acid substitution in CFTR converts ATP to an inhibitory ligand.
    Lin WY; Jih KY; Hwang TC
    J Gen Physiol; 2014 Oct; 144(4):311-20. PubMed ID: 25225552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbon monoxide-releasing molecules inhibit the cystic fibrosis transmembrane conductance regulator Cl
    Rodrat M; Jantarajit W; Ng DRS; Harvey BSJ; Liu J; Wilkinson WJ; Charoenphandhu N; Sheppard DN
    Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L997-L1009. PubMed ID: 32936026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse cystic fibrosis transmembrane conductance regulator forms cAMP-PKA-regulated apical chloride channels in cortical collecting duct.
    Lu M; Dong K; Egan ME; Giebisch GH; Boulpaep EL; Hebert SC
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6082-7. PubMed ID: 20231442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of G551D-CFTR (cystic fibrosis transmembrane conductance regulator) potentiation by a high affinity ATP analog.
    Bompadre SG; Li M; Hwang TC
    J Biol Chem; 2008 Feb; 283(9):5364-9. PubMed ID: 18167357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CFTR channels expressed in CHO cells do not have detectable ATP conductance.
    Grygorczyk R; Tabcharani JA; Hanrahan JW
    J Membr Biol; 1996 May; 151(2):139-48. PubMed ID: 8661502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altering intracellular pH reveals the kinetic basis of intraburst gating in the CFTR Cl
    Chen JH; Xu W; Sheppard DN
    J Physiol; 2017 Feb; 595(4):1059-1076. PubMed ID: 27779763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl- channels by non-sulphonylurea hypoglycaemic agents.
    Cai Z; Lansdell KA; Sheppard DN
    Br J Pharmacol; 1999 Sep; 128(1):108-18. PubMed ID: 10498841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of CFTR Cl- channel gating by ATP binding and hydrolysis.
    Ikuma M; Welsh MJ
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8675-80. PubMed ID: 10880569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain.
    Csanády L; Chan KW; Nairn AC; Gadsby DC
    J Gen Physiol; 2005 Jan; 125(1):43-55. PubMed ID: 15596536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological and pharmacological characterization of the N1303K mutant CFTR.
    DeStefano S; Gees M; Hwang TC
    J Cyst Fibros; 2018 Sep; 17(5):573-581. PubMed ID: 29887518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CFTR Cl- channel and CFTR-associated ATP channel: distinct pores regulated by common gates.
    Sugita M; Yue Y; Foskett JK
    EMBO J; 1998 Feb; 17(4):898-908. PubMed ID: 9463368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating.
    Cui L; Aleksandrov L; Hou YX; Gentzsch M; Chen JH; Riordan JR; Aleksandrov AA
    J Physiol; 2006 Apr; 572(Pt 2):347-58. PubMed ID: 16484308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clusters of Cl- channels in CFTR-expressing Sf9 cells switch spontaneously between slow and fast gating modes.
    Larsen EH; Price EM; Gabriel SE; Stutts MJ; Boucher RC
    Pflugers Arch; 1996 Jul; 432(3):528-37. PubMed ID: 8766014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.